Literature DB >> 24931475

A comparison of Doppler and biophysical findings between liveborn and stillborn growth-restricted fetuses.

Sarah Crimmins1, Andrea Desai1, Dana Block-Abraham1, Christoph Berg2, Ulrich Gembruch2, Ahmet Alexander Baschat3.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the surveillance characteristics that precede stillbirth in growth-restricted fetuses that receive integrated Doppler and biophysical profile scoring (BPS). STUDY
DESIGN: Nine hundred eighty-seven singleton pregnancies that were complicated by fetal growth restriction had multivessel Doppler scans (umbilical and middle cerebral arteries [MCA], ductus venosus, and umbilical vein) and BPS. Surveillance findings were compared between live births and stillbirths.
RESULTS: Forty-seven stillbirths occurred in 2 clusters, 37 at <34 weeks of gestation and 10 thereafter. Before 34 weeks of gestation, stillbirths had parallel escalation of umbilical artery and ductus venosus Doppler findings followed by abnormal BPS. At ≥34 weeks of gestation, only a decline in MCA pulsatility index was observed, and 75% of stillbirths were unanticipated by the BPS.
CONCLUSION: Before 34 weeks of gestation, multivessel Doppler abnormality anticipates an abnormal BPS and subsequent stillbirth. After 34 weeks of gestation, stillbirths occur after MCA brain-sparing in a shorter interval than predicted by a normal BPS. Recognition of these differences in clinical behavior requires consideration for the planning of monitoring intervals in preterm and term fetal growth restriction.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Doppler; biophysical profile; fetal growth restriction; stillbirth

Mesh:

Year:  2014        PMID: 24931475     DOI: 10.1016/j.ajog.2014.06.022

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  10 in total

1.  FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction.

Authors:  Nir Melamed; Ahmet Baschat; Yoav Yinon; Apostolos Athanasiadis; Federico Mecacci; Francesc Figueras; Vincenzo Berghella; Amala Nazareth; Muna Tahlak; H David McIntyre; Fabrício Da Silva Costa; Anne B Kihara; Eran Hadar; Fionnuala McAuliffe; Mark Hanson; Ronald C Ma; Rachel Gooden; Eyal Sheiner; Anil Kapur; Hema Divakar; Diogo Ayres-de-Campos; Liran Hiersch; Liona C Poon; John Kingdom; Roberto Romero; Moshe Hod
Journal:  Int J Gynaecol Obstet       Date:  2021-03       Impact factor: 3.561

Review 2.  Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.

Authors:  Emily J Su
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

Review 3.  Clinical Opinion: The diagnosis and management of suspected fetal growth restriction: an evidence-based approach.

Authors:  Christoph C Lees; Roberto Romero; Tamara Stampalija; Andrea Dall'Asta; Greggory A DeVore; Federico Prefumo; Tiziana Frusca; Gerard H A Visser; John C Hobbins; Ahmet A Baschat; Caterina M Bilardo; Henry L Galan; Stuart Campbell; Dev Maulik; Francesc Figueras; Wesley Lee; Julia Unterscheider; Herbert Valensise; Fabricio Da Silva Costa; Laurent J Salomon; Liona C Poon; Enrico Ferrazzi; Giancarlo Mari; Giuseppe Rizzo; John C Kingdom; Torvid Kiserud; Kurt Hecher
Journal:  Am J Obstet Gynecol       Date:  2022-01-10       Impact factor: 10.693

4.  Early-onset fetal growth restriction treated with the long-acting phosphodiesterase-5 inhibitor tadalafil: a case report.

Authors:  Mito Sakamoto; Kazuhiro Osato; Michiko Kubo; Masafumi Nii; Hiroaki Tanaka; Nao Murabayashi; Takashi Umekawa; Yuki Kamimoto; Tomoaki Ikeda
Journal:  J Med Case Rep       Date:  2016-11-08

5.  The PLANES study: a protocol for a randomised controlled feasibility study of the placental growth factor (PlGF) blood test-informed care versus standard care alone for women with a small for gestational age fetus at or after 32 + 0 weeks' gestation.

Authors:  Joanna Gent; Sian Bullough; Jane Harrold; Richard Jackson; Kerry Woolfall; Lazaros Andronis; Louise Kenny; Christine Cornforth; Alexander E P Heazell; Emily Benbow; Zarko Alfirevic; Andrew Sharp
Journal:  Pilot Feasibility Stud       Date:  2020-11-19

6.  An integrated approach based on advanced CTG parameters and Doppler measurements for late growth restriction management.

Authors:  Giovanni Magenes; Giuseppe Maria Maruotti; Maria Gabriella Signorini; Giuseppina Esposito; Nicolò Pini; Salvatore Tagliaferri; Marta Campanile; Fulvio Zullo
Journal:  BMC Pregnancy Childbirth       Date:  2021-11-16       Impact factor: 3.007

Review 7.  Fetal growth restriction and stillbirth: Biomarkers for identifying at risk fetuses.

Authors:  Victoria J King; Laura Bennet; Peter R Stone; Alys Clark; Alistair J Gunn; Simerdeep K Dhillon
Journal:  Front Physiol       Date:  2022-08-19       Impact factor: 4.755

8.  Influence of Birthweight on the Prospective Stillbirth Risk in the Third Trimester: A Cross-Sectional Cohort Study.

Authors:  Stephen Contag; Clayton Brown; Sarah Crimmins; Katherine Goetzinger
Journal:  AJP Rep       Date:  2016-07

Review 9.  Fetal movements as a predictor of health.

Authors:  Jonathan Lai; Niamh C Nowlan; Ravi Vaidyanathan; Caroline J Shaw; Christoph C Lees
Journal:  Acta Obstet Gynecol Scand       Date:  2016-09       Impact factor: 3.636

10.  Ultrasound prediction of adverse perinatal outcome at diagnosis of late-onset fetal growth restriction.

Authors:  A Dall'Asta; T Stampalija; F Mecacci; M Minopoli; G B L Schera; G Cagninelli; C Ottaviani; I Fantasia; M Barbieri; F Lisi; S Simeone; T Ghi; T Frusca
Journal:  Ultrasound Obstet Gynecol       Date:  2022-03       Impact factor: 8.678

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.